UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

274 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with dermatitis

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S49

2021

Volltextzugriff (PDF)

301 The impact of tailored delivery of education on engagement and disease severity: A randomized controlled trial among adults with psoriasis

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S51

2022

Volltextzugriff (PDF)

33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)

Biology of blood and marrow transplantation, 2007, Vol.13 (2), p.15-15

2007

Volltextzugriff (PDF)

373 Do less satisfied patients utilize more healthcare resources? A population study among U.S. adults with psoriasis

Journal of investigative dermatology, 2020-07, Vol.140 (7), p.S48-S48

2020

Volltextzugriff (PDF)

450 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with skin cancer

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S77-S77

2023

Volltextzugriff (PDF)

Bone marrow transplantation for multiple myeloma

European journal of cancer (1990), 1999-09, Vol.35, p.S304-S304

Apperley, J.F.

1999

Volltextzugriff (PDF)

Bone marrow transplantation for patients with chronic myeloid leukemia

The New England journal of medicine, 1986-01, Vol.314 (4), p.202

1986

Volltextzugriff (PDF)

Circulating Stem Cells in Mice Treated With Cyclophosphamide

Blood, 1992-07, Vol.80 (1), p.264-269

1992

Volltextzugriff (PDF)

Complete remission after autografting for chronic myeloid leukaemia

Leukemia research, 1987, Vol.11 (12), p.1115-1117

1987

Volltextzugriff (PDF)

Cytogenetic Events After Bone Marrow Transplantation for Chronic Myeloid Leukemia in Chronic Phase

Blood, 1988-05, Vol.71 (5), p.1179-1186

1988

Volltextzugriff (PDF)

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Leukemia, 2008-06, Vol.22 (6), p.1200-1206

2008

Volltextzugriff (PDF)

Dasatinib (SPRYCEL®) Efficacy and Safety in Patients (pts) with Chronic Myelogenous Leukemia in Lymphoid (CML-LB) or Myeloid Blast (CML-MB) Phase Who Are Imatinib-Resistant (Im-r) or -Intolerant (Im-i)

Blood, 2006-11, Vol.108 (11), p.745-745

2006

Volltextzugriff (PDF)

Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Myelogenous Leukemia in Accelerated Phase (AP-CML) That Is Imatinib-Resistant (im-r) or -Intolerant (im-i): Updated Results of the CA180–005 'START-A' Phase II Study

Blood, 2006-11, Vol.108 (11), p.2160-2160

2006

Volltextzugriff (PDF)

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

British journal of haematology, 1997-09, Vol.98 (4), p.973-982

1997

Volltextzugriff (PDF)

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Leukemia, 2010-01, Vol.24 (1), p.58-65

2010

Volltextzugriff (PDF)

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.824-830

2012

Volltextzugriff (PDF)

Efficacy of Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Resistant to or Intolerant of Imatinib: Updated Results of the CA180013 ‘START-C' Phase II Study

Blood, 2006-11, Vol.108 (11), p.164-164

2006

Volltextzugriff (PDF)

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1046-1050

2012

Volltextzugriff (PDF)

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

British journal of haematology, 2007-03, Vol.136 (6), p.833-836

2007

Volltextzugriff (PDF)

FOSCARNET FOR CYTOMEGALOVIRUS PNEUMONITIS

The Lancet (British edition), 1985-05, Vol.325 (8438), p.1151-1151

1985

Volltextzugriff (PDF)

genes in chronic lymphocytic leukaemia: highly skewed V gene segment usage with similar CDR3 sequences

Leukemia, 2008-05, Vol.22 (5), p.1073

2008

Volltextzugriff (PDF)

Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (4), p.401-403

2007

Volltextzugriff (PDF)

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.364-367

2011

Volltextzugriff (PDF)

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF

Bone marrow transplantation (Basingstoke), 2012-07, Vol.47 (7), p.1003-1005

2012

Volltextzugriff (PDF)

Histocompatible Unrelated Volunteer Donors Compared With HLA Nonidentical Family Donors in Marrow Transplantation for Aplastic Anemia and Leukemia

Blood, 1986-12, Vol.68 (6), p.1322-1328

1986

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Humans
(39)
Life Sciences & Biomedicine
(39)
Hematology
(35)
Biological And Medical Sciences
(30)
Medical Sciences
(28)
Male
(25)
Female
(24)
Oncology
(24)
Adult
(22)
Middle Aged
(21)
Bone Marrow
(19)
Stem Cell Transplantation
(17)
Transplantation
(17)
Aged
(16)
Immunology
(15)
Biophysics
(14)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(13)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(13)
Hematologic And Hematopoietic Diseases
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

274 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with dermatitis

301 The impact of tailored delivery of education on engagement and disease severity: A randomized controlled trial among adults with psoriasis

33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)

373 Do less satisfied patients utilize more healthcare resources? A population study among U.S. adults with psoriasis

450 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with skin cancer

Bone marrow transplantation for multiple myeloma

Bone marrow transplantation for patients with chronic myeloid leukemia

Circulating Stem Cells in Mice Treated With Cyclophosphamide

Complete remission after autografting for chronic myeloid leukaemia

Cytogenetic Events After Bone Marrow Transplantation for Chronic Myeloid Leukemia in Chronic Phase

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Dasatinib (SPRYCEL®) Efficacy and Safety in Patients (pts) with Chronic Myelogenous Leukemia in Lymphoid (CML-LB) or Myeloid Blast (CML-MB) Phase Who Are Imatinib-Resistant (Im-r) or -Intolerant (Im-i)

Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Myelogenous Leukemia in Accelerated Phase (AP-CML) That Is Imatinib-Resistant (im-r) or -Intolerant (im-i): Updated Results of the CA180–005 'START-A' Phase II Study

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Efficacy of Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Resistant to or Intolerant of Imatinib: Updated Results of the CA180013 ‘START-C' Phase II Study

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

FOSCARNET FOR CYTOMEGALOVIRUS PNEUMONITIS

genes in chronic lymphocytic leukaemia: highly skewed V gene segment usage with similar CDR3 sequences

Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF

Histocompatible Unrelated Volunteer Donors Compared With HLA Nonidentical Family Donors in Marrow Transplantation for Aplastic Anemia and Leukemia

Suchergebnisse filtern